How the right partnerships are helping streamline CGT manufacturing through robotics and digital tools.

Study investigates why vial choices matters for frozen biopharmaceutical storage.

US-based pharmaceutical associations fear the supply chain repercussions of tariffs, and offer advice for a more sustainable alternative.

So much has already been achieved with RNA – and it’s only going to get better.

We speak with Sanofi’s Anju Bhalla about its appeal against NICE’s final draft guidance for Sarclisa.

AI is set to be a key disruptor in the pharma industry. Here are two perspectives on how it could change drug development.

Senate committee votes in favor of the nomination; full Senate vote will be next.

Being part of the cell and gene therapy field is an incredible privilege, according to Frank Mathias, CEO, Oxford Biomedica.

Here’s a roundup of ten of the most eye-catching deals so far in 2025.

A look at how biosimilars can increase patient access to essential medicines, as well as improve performance in healthcare systems.